Using in Vivo Confocal Microscope to Evaluate the Corneal Wound Healing After Various Ocular Surgeries
Study Details
Study Description
Brief Summary
Although epi-keratome laser-assisted in situ keratomileusis (Epi-LASIK), penetrating keratoplasty and pars plana vitrectomy with corneal epithelial debridement for diabetic retinopathy are surgeries commonly performed, the time-sequential, in vivo microscopic wound healing process is not fully understood. The purpose of this study is to study the healing of corneal wounds after Epi-LASIK, penetrating keratoplasty and pars plana vitrectomy with corneal epithelial debridement for diabetic retinopathy by in vivo confocal microscopy, an easily performed and non-invasive procedure. We plan to enroll 40 eyes of 40 patients in each of these three surgeries. In Epi-LASIK, slit-lamp biomicroscopy, in vivo confocal microscopy, and visual acuity are recorded before and 1, 3, and 7 days after surgery. The eyes are examined weekly in the first month and at 3 and 6 months. For penetrating keratoplasty and pars plana vitrectomy with corneal epithelial debridement, slit-lamp biomicroscopy, in vivo confocal microscopy, and visual acuity are recorded before and weekly in the first month after surgeries and at 3 and 6 months. Selected images of the corneal basal/apical surface epithelia, stromal reactions and corneal endothelial conditions by in vivo confocal microscopy are evaluated qualitatively for the cellular morphology and density.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Although epi-keratome laser-assisted in situ keratomileusis (Epi-LASIK), penetrating keratoplasty and pars plana vitrectomy with corneal epithelial debridement for diabetic retinopathy are surgeries commonly performed, the time-sequential, in vivo microscopic wound healing process is not fully understood. The purpose of this study is to study the healing of corneal wounds after Epi-LASIK, penetrating keratoplasty and pars plana vitrectomy with corneal epithelial debridement for diabetic retinopathy by in vivo confocal microscopy, an easily performed and non-invasive procedure. We plan to enroll 40 eyes of 40 patients in each of these three surgeries. In Epi-LASIK, slit-lamp biomicroscopy, in vivo confocal microscopy, and visual acuity are recorded before and 1, 3, and 7 days after surgery. The eyes are examined weekly in the first month and at 3 and 6 months. For penetrating keratoplasty and pars plana vitrectomy with corneal epithelial debridement, slit-lamp biomicroscopy, in vivo confocal microscopy, and visual acuity are recorded before and weekly in the first month after surgeries and at 3 and 6 months. Selected images of the corneal basal/apical surface epithelia, stromal reactions and corneal endothelial conditions by in vivo confocal microscopy are evaluated qualitatively for the cellular morphology and density.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Corneal wounds after Epi-LASIK Corneal wounds after Epi-LASIK |
|
penetrating keratoplasty Corneal wound after penetrating keratoplasty |
|
corneal epithelial debridement Corneal wound after pars plana vitrectioy with corneal epithelial debridement for diabetic retinopathy |
Outcome Measures
Primary Outcome Measures
- cellular morphology and density [before surgery and 1, 3, and 7 days after surgeryfirst month and at 3 and 6 months]
Secondary Outcome Measures
- corneal basal/apical surface epithelia, stromal reactions and corneal endothelial conditions [before and 1, 3, and 7 days after surgery, first month and at 3 and 6 months]
- visual acuity [before and 1, 3, and 7 days after surgery, first month and at 3 and 6 months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
patients receiving various ocular surgeries
-
no previous ocular surgery
-
tear break up time longer than 10 seconds
-
Shirmer test II larger than 5 mm
-
no presurgical corneal disease confirmed by slit lamp and in vivo confocal
-
no limbus defect
-
proliferative retinopathy underwent vitrectomy combining corneal epithelial scrating
Exclusion Criteria:
-
can not complete follow up
-
ineligible for ocular surgery
-
eyelid closure incomplete
-
glaucoma
-
corneal defect or oculoneuropathy not caused by diabetes
-
severe dry eye disease
-
limbus defect
-
pregnant
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Wei-Li Chen | Taipei | Taiwan |
Sponsors and Collaborators
- National Taiwan University Hospital
Investigators
- Principal Investigator: Fung-Rong Hu, MD, Department of Ophthalmology, National Taiwan Universtiy Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 200702038R